Skip to main content
Erschienen in: Rheumatology International 2/2004

01.03.2004 | Original Article

Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis

verfasst von: Salih Ozgocmen, Sadık Sogut, Ozge Ardicoglu, Ersin Fadillioglu, Irfan Pekkutucu, Omer Akyol

Erschienen in: Rheumatology International | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract

In this study, serum antioxidant and oxygen derived free radical status of patients with ankylosing spondylitis (AS) was investigated and compared with that of age- and sex-matched healthy controls. The relationship of these parameters to disease activity indices was also examined. Thirty patients with AS not currently under disease-modifying antirheumatic drug (DMARD) treatment (e.g., sulfasalazine or methotrexate) (15 active and 15 inactive) and 16 age- and sex-matched healthy controls were included in the study. Catalase (EC 1.11.1.6), total (Cu-Zn and Mn) superoxide dismutase (SOD) (EC 1.15.1.1) activities, and malondialdehyde (MDA), nitrite (NO2 -), and nitrate (NO3 -) levels as indices of nitric oxide (NO) production were evaluated using appropriate methods. There was no statistically significant difference found in SOD activity or NO and MDA levels between active and inactive patients. Inactive patients showed no significant difference in all the measured oxidant/antioxidant parameters when compared to healthy controls. Active patients had significantly higher levels of MDA and catalase enzyme activity (P=0.002 and P=0.007, respectively). There was no significant correlation between oxidant/antioxidant parameters and disease activity, C-reactive protein, erythrocyte sedimentation rate, or Bath Ankylosing Spondylitis Disease Activity Index (CRP, ESR, or BASDAI) in either group, except catalase enzyme activity, which had a significant correlation with CRP and ESR levels in active patients (r=0.69 and P=0.004, r=0.52 and P=0.04, respectively). Our results indicate that oxidative stress and lipid peroxidation are accelerated in untreated patients with active AS. Serum catalase activity may be closely related to disease activity. In this regard, we underscore the likely benefit of some therapeutic interventions including high-potential antioxidants that will potentiate the antioxidant defense mechanism and reduce peroxidation in the management of AS.
Literatur
1.
Zurück zum Zitat Khan MA (1994) Ankylosing spondylitis: clinical features. In: Klippel J, Dieppe P (eds) Rheumatology. Mosby Year Book Europe, London, 3:25.1–3.25.10 Khan MA (1994) Ankylosing spondylitis: clinical features. In: Klippel J, Dieppe P (eds) Rheumatology. Mosby Year Book Europe, London, 3:25.1–3.25.10
2.
Zurück zum Zitat Blake DR, Merry P, Unsworth J, Kidd BL, Outhwaite JM, Ballard R et al (1989) Hypoxic-reperfusion injury in the inflamed human joint. Lancet 1:289–293PubMed Blake DR, Merry P, Unsworth J, Kidd BL, Outhwaite JM, Ballard R et al (1989) Hypoxic-reperfusion injury in the inflamed human joint. Lancet 1:289–293PubMed
3.
Zurück zum Zitat Lunec J, Halloran SP, White AG, Dormandy TL (1981) Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 8:233–245PubMed Lunec J, Halloran SP, White AG, Dormandy TL (1981) Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 8:233–245PubMed
4.
Zurück zum Zitat Imadaya A, Terasawa K, Tosa H, Okamoto M, Toriizuka K (1988) Erythrocyte antioxidant enzymes are reduced in patients with rheumatoid arthritis. J Rheumatol 15:1628–1631PubMed Imadaya A, Terasawa K, Tosa H, Okamoto M, Toriizuka K (1988) Erythrocyte antioxidant enzymes are reduced in patients with rheumatoid arthritis. J Rheumatol 15:1628–1631PubMed
5.
Zurück zum Zitat Abella A, Clerc D, Chalas J, Baret A, Leluc R, Lindenbaum A (1987) Concentration en superoxyde dismutase (cuivre et manganèse), catalase et glutathion peroxydase dans les hématies, les plaquettes et le plasma de sujets atteints de polyarthrite rhumatoïde. Ann Biol Clin 45:152–155 Abella A, Clerc D, Chalas J, Baret A, Leluc R, Lindenbaum A (1987) Concentration en superoxyde dismutase (cuivre et manganèse), catalase et glutathion peroxydase dans les hématies, les plaquettes et le plasma de sujets atteints de polyarthrite rhumatoïde. Ann Biol Clin 45:152–155
6.
Zurück zum Zitat Gambhir JK, Lali P, Jain AK (1997) Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 30:351–355CrossRefPubMed Gambhir JK, Lali P, Jain AK (1997) Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 30:351–355CrossRefPubMed
7.
Zurück zum Zitat Floyd RA (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 4:2587–2597PubMed Floyd RA (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 4:2587–2597PubMed
Zurück zum Zitat 8-Wendling D, Didier JM, Vuitton DA (1991) The phagocyte oxidative metabolism function in ankylosing spondylitis. Rheumatol Int 11:187–189PubMed 8-Wendling D, Didier JM, Vuitton DA (1991) The phagocyte oxidative metabolism function in ankylosing spondylitis. Rheumatol Int 11:187–189PubMed
9.
Zurück zum Zitat Biasi D, Carletto A, Caramaschi P, Bellavite P, Andrioli G, Caraffi M, et al (1995) Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients. Clin Exp Rheumatol 13:623–627PubMed Biasi D, Carletto A, Caramaschi P, Bellavite P, Andrioli G, Caraffi M, et al (1995) Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients. Clin Exp Rheumatol 13:623–627PubMed
10.
Zurück zum Zitat Ho KJ, Chen PQ, Chang CY, Lu FJ (2000) The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence. Ann Rheum Dis 59:338–341CrossRefPubMed Ho KJ, Chen PQ, Chang CY, Lu FJ (2000) The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence. Ann Rheum Dis 59:338–341CrossRefPubMed
11.
Zurück zum Zitat Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMed Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMed
12.
Zurück zum Zitat Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Daugados M (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 38:878–882 Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Daugados M (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 38:878–882
13.
Zurück zum Zitat Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 673–677 Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 673–677
14.
Zurück zum Zitat Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500PubMed Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500PubMed
15.
Zurück zum Zitat Wasowicz W, Neve J, Peretz A (1993) Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 39:2522–2526PubMed Wasowicz W, Neve J, Peretz A (1993) Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 39:2522–2526PubMed
16.
Zurück zum Zitat Cortas NK, Wakid NW (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36:1440–1443PubMed Cortas NK, Wakid NW (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36:1440–1443PubMed
17.
Zurück zum Zitat Clancy RM, Amin AR, Abramson SB (1998) The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141–1151CrossRefPubMed Clancy RM, Amin AR, Abramson SB (1998) The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141–1151CrossRefPubMed
18.
Zurück zum Zitat Stichtenoth DO, Frolich JC (1998) Nitric oxide and inflammatory joint diseases. Br J Rheumatol 37:246–257CrossRefPubMed Stichtenoth DO, Frolich JC (1998) Nitric oxide and inflammatory joint diseases. Br J Rheumatol 37:246–257CrossRefPubMed
19.
Zurück zum Zitat Malinski T, Taha Z (1992) Nitric oxide release form a single cell measured in situ by a porphyrinic-based microsensor. Nature 358:676–678 Malinski T, Taha Z (1992) Nitric oxide release form a single cell measured in situ by a porphyrinic-based microsensor. Nature 358:676–678
20.
Zurück zum Zitat Koltuksuz U, Irmak MK, Karaman A, Uz E, Var A, Ozyurt H et al (2000) Testicular nitric oxide levels after unilateral testicular torsion-detorsion in rats pretreated with caffeic acid phenethyl ester. Urol Res 28:360–363PubMed Koltuksuz U, Irmak MK, Karaman A, Uz E, Var A, Ozyurt H et al (2000) Testicular nitric oxide levels after unilateral testicular torsion-detorsion in rats pretreated with caffeic acid phenethyl ester. Urol Res 28:360–363PubMed
21.
Zurück zum Zitat Sahin S, Sogut S, Ozyurt H, Uz E, Ilhan A, Akyol O (2002) Tissue xanthine oxidase activity and nitric oxide levels after spinal cord ischemia/reperfusion injury in rabbits: comparison of caffeic acid phenethyl ester (CAPE) and methylprednisolone. Neurosci Res Commun 31:111–121CrossRef Sahin S, Sogut S, Ozyurt H, Uz E, Ilhan A, Akyol O (2002) Tissue xanthine oxidase activity and nitric oxide levels after spinal cord ischemia/reperfusion injury in rabbits: comparison of caffeic acid phenethyl ester (CAPE) and methylprednisolone. Neurosci Res Commun 31:111–121CrossRef
22.
Zurück zum Zitat Stichtenoth DO, Wollenhaupt J, Andersone D, Zeidler H, Frolich JC (1995) Elevated serum nitrate concentrations in active spondylarthropathies. Br J Rheumatol 34:616–619PubMed Stichtenoth DO, Wollenhaupt J, Andersone D, Zeidler H, Frolich JC (1995) Elevated serum nitrate concentrations in active spondylarthropathies. Br J Rheumatol 34:616–619PubMed
23.
Zurück zum Zitat Pullar T, Zoma A, Capell HA, Khan MF, Brown DH, Smith WE (1987) Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulfasalazine. Br J Rheumatol 26:202–206PubMed Pullar T, Zoma A, Capell HA, Khan MF, Brown DH, Smith WE (1987) Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulfasalazine. Br J Rheumatol 26:202–206PubMed
24.
Zurück zum Zitat Toth KM, Berger EM, Beehler CJ, Repine JE (1986) Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than do erythrocytes from nonsmokers. Am J Respir Dis 134:281–284 Toth KM, Berger EM, Beehler CJ, Repine JE (1986) Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than do erythrocytes from nonsmokers. Am J Respir Dis 134:281–284
25.
Zurück zum Zitat Akyol O, Isci N, Temel I, Ozgocmen S, Uz E, Murat M et al (2001) The relationships between plasma and erythrocyte antioxidant enzymes and lipid peroxidation in patients with rheumatoid arthritis. Joint Bone Spine 68:311–317CrossRef Akyol O, Isci N, Temel I, Ozgocmen S, Uz E, Murat M et al (2001) The relationships between plasma and erythrocyte antioxidant enzymes and lipid peroxidation in patients with rheumatoid arthritis. Joint Bone Spine 68:311–317CrossRef
Metadaten
Titel
Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis
verfasst von
Salih Ozgocmen
Sadık Sogut
Ozge Ardicoglu
Ersin Fadillioglu
Irfan Pekkutucu
Omer Akyol
Publikationsdatum
01.03.2004
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 2/2004
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-003-0335-y

Weitere Artikel der Ausgabe 2/2004

Rheumatology International 2/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.